Bolloré Logistics USA received its first IATA CEIV Pharma certification for its Chicago branch, for the handling of temperature-controlled healthcare and life science products, on March 30. The certification officially recognises Bolloré Logistics Chicago's commitment in handling time-sensitive, temperature-controlled and often life-saving pharmaceutical products with increased safety, security, compliance and efficiency.
Located at O'Hare airport, the 12,000 square foot partner pharma warehouse offers landside and airside acceptance capabilities and significant temperature-controlled storage. The dedicated operation has its own docks and manoeuvring area for the loading and unloading of temperature-controlled pharmaceutical shipments and incorporates:
- Three-chamber facility ranges in temperature from 2 – 8 degrees Celsius
- A 2 – 8 degree Celsius cooler at the acceptance and delivery docks
- A large 15 – 25 degree Celsius storage and build-up area offering ten electrical connections for active, running containers
- Dedicated temperature-controlled loading/unloading bays minimising the risks of temperature deviations.
New technologies used in the facility include real-time monitoring ensuring constant tracking of shipments with reports of recorded temperatures and deviations available on demand.
"Through training, quality audits and validation, the IATA CEIV Pharma certification ensures the integrity of every pharmaceutical and healthcare product in the airfreight supply chain," said Emilie Foray, Chicago branch manager at Bolloré Logistics USA. "The IATA CEIV Pharma certification attests the highest service for life sciences and healthcare customers thought uniform and compliant processes. Receiving this CEIV Pharma accreditation confirms the high standards we set with our teams of experts to further strengthen our product for the benefit of our customers."
"The key to reaching this milestone was the hard work, dedication, focus and support from all our staff in ensuring the quality monitoring of the components of the CEIV program," said Yves Laforgue, CEO Americas. "An industry-leading set like the IATA CEIV Pharma certification, combined with our innovation and CSR commitment, will help make us enhance our value proposition for our existing customers in the pharmaceutical industry, gain new business and meet market demand."